Clinical Trials Directory

Trials / Unknown

UnknownNCT01586754

Subclinical Organ Damage in Overweight and Obese Patients: Does Presence of Metabolic Syndrome Matter?

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Goztepe Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Microalbuminuria and homocysteine levels are shown to be markers for endothelial dysfunction and subclinical organ damage and predictors of cardiovascular risk in several epidemiologic and randomized clinical trials. Carotis intima-media thickness is also found to be elevated in early stages of atherosclerosis. Recent studies have shown correlations between homocysteine, microalbumin levels and carotis intima-media thickness in type 2 diabetics but no data exists for obese or overweight patients who also have metabolic syndrome, in terms of markers of subclinical organ damage. Since obesity is a risk factor for cardiovascular disease and since it is known that patients with metabolic syndrome are at higher risk of cardiovascular events, the investigators wanted to examine whether there is an association between homocysteine, microalbumin levels and carotid intima-media thickness in patients with or without metabolic syndrome, who are either overweight or obese.

Conditions

Timeline

Start date
2011-10-01
Primary completion
2012-04-01
Completion
2012-05-01
First posted
2012-04-27
Last updated
2012-04-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01586754. Inclusion in this directory is not an endorsement.

Subclinical Organ Damage in Overweight and Obese Patients: Does Presence of Metabolic Syndrome Matter? (NCT01586754) · Clinical Trials Directory